Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04831164 · ClinicalTrials.gov registry record

Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study

A clinical trial of Rotator Cuff Tears, sponsored by University of Michigan.

Recruiting
Registry status
3,500
Enrollment target
10
Study locations

NCT04831164 is a study of Rotator Cuff Tears that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 3,500 participants, above the 1,106-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (216% higher). The trial reports 10 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04831164, a study of Rotator Cuff Tears, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
3,500 participants
Enrollment target
10
Study locations

Study Summary

Rotator cuff tear is one of the most common reasons to seek musculoskeletal care, and cuff repair is one of the fastest growing ambulatory surgery procedures. However, the etiology of cuff tears, reasons for variability treatment success, and causes of FI are poorly understood. A large-scale genome-wide association studies (GWAS) using imaging-verified rotator cuff tear cases and controls can address limitations in rigor of prior research and assess the genetic basis of FI and functional outcomes of cuff tear treatments. Primary Objective: To conduct a case-control GWAS of imaging-verified symptomatic rotator cuff tear in approximately 3000-6000 individuals and replicate findings in an independent set of 3000-6000 or more imaging-verified individuals to identify common variants in several genetic loci that increase risk for rotator cuff tears. Hypothesis: Common variants in several genetic loci increase risk for rotator cuff tears. Secondary Objectives: 1. To perform an imputed transcriptome-wide association study (TWAS) to identify and prioritize gene targets associated with rotator cuff tear by integrating GWAS summary statistics and gene-expression weights from muscle and adipose tissue available in the GTEx project. Hypothesis: Genetically predicted gene expression of multiple genes in muscle and adipose tissue are associated with rotator cuff tear. 2. To identify if single nucleotide polymorphisms (SNPs) associated with rotator cuff tear and their genetic risk score (GRS) predict improved pain and function as measured by American Shoulder and Elbow Surgeons Standardized Form (ASES) and other outcome measures. Hypothesis: Select SNPs and GRS predict ASES outcome. 3. To identify genetic variants associated with Fatty Infiltration (FI) in patients with cuff tears in a two stage GWAS of imaged rotator cuffs and to prioritize gene targets through an imputed-TWAS in muscle and adipose tissue. Hypothesis: Multiple genetic variants are associated with FI a

Conditions Studied

Interventions

  • OTHER NA (not an interventional study)

Study Locations (10)

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Boston Medical Center - Boston
  • Beth Israel Deaconess Medical Center - Boston

Texas

  • Parkland Health and Hospital System - Dallas
  • University of Texas Southwestern Medical Center - Dallas

Iowa

  • University of Iowa - Iowa City

Michigan

  • University of Michigan - Ann Arbor

Ohio

  • Ohio State University - Columbus

South Dakota

  • Orthopedic Institute - Sioux Falls

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 3,500 participants
Start Date 2021-03-04
Est. Completion 2031-12-31

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT04831164

The ClinicalTrials.gov registry entry for NCT04831164 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,106-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (216% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rotator Cuff Tears appearing as the primary indexed condition, and to 1 intervention - of which NA (not an interventional study) is the first listed.

NCT04831164 reports 10 study locations spanning 7 distinct geographic areas - top geographies include Massachusetts, Texas, Iowa.

Frequently Asked Questions

What is clinical trial NCT04831164 about?

NCT04831164 is a clinical study titled "Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study". Rotator cuff tear is one of the most common reasons to seek musculoskeletal care, and cuff repair is one of the fastest growing ambulatory surgery procedures. However, the etiology of cuff tears, reasons for variability treatment success, and causes of FI are poorly understood. A large-scale genome-...

What is the current status of trial NCT04831164?

This trial is currently recruiting. The enrollment target is 3,500 participants. The study started on 2021-03-04. Estimated completion is 2031-12-31.

What conditions does trial NCT04831164 study?

This clinical trial studies the following conditions: Rotator Cuff Tears.

What interventions are being tested in trial NCT04831164?

The interventions under investigation include: NA (not an interventional study) (OTHER).

Who is sponsoring clinical trial NCT04831164?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04831164 being conducted?

This trial has 10 study locations across Iowa, Massachusetts, Michigan, Ohio, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rotator Cuff Tears

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.